UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Back to CTMX Full portfolio

Position in CTMX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$824,171

-$66,009 QoQ

Shares Held

219,779

+16.0% QoQ

Ownership

0.101%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 178 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 40% Shared 0% None 60%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. CTMX ranks #124 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,086,683	$1,533,248,041
2	REGN	Regeneron Pharmaceuticals, Inc.	716,560	$446,803,817
3	ALNY	Alnylam Pharmaceuticals, Inc.	727,848	$219,104,078
4	INCY	Incyte Corp	1,508,720	$171,028,494
5	RVMD	Revolution Medicines, Inc.	912,335	$170,862,094
6	INSM	INSMED Inc	1,335,071	$142,345,265
7	IONS	Ionis Pharmaceuticals Inc	1,454,672	$115,340,938
8	MRNA	Moderna, Inc.	1,521,849	$106,575,080

All Filings in CTMX

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$824,171	219,779	+16.0%	Shares	Defined	2026-08-13
2026-03-31	$890,180	189,400	+194.2%	Shares	Sole	2026-05-13
2021-09-30	$327,636	64,369	-0.7%	Shares	Defined	2021-11-15
2021-06-30	$410,492	64,849	+119.1%	Shares	Defined	2021-08-16
2021-03-31	$228,768	29,595	-40.1%	Shares	Sole	2021-05-14
2020-12-31	$323,379	49,371	0.0%	Shares	Defined	2021-03-01
2020-09-30	$328,316	49,371	+59.6%	Shares	Defined	2020-11-13
2020-06-30	$257,654	30,931	+12.8%	Shares	Defined	2020-08-14
2020-03-31	$210,296	27,418	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.